Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding
Biotech
ARPA-H invests in Kernal's mRNA cell therapy
The financing will help Kernal advance its early-stage program KR-402 through clinical development in multiple sclerosis and B-cell malignancies.
Gabrielle Masson
Oct 7, 2025 3:20pm
Galimedix's oral Alzheimer's candidate clears ph. 1 safety test
Sep 12, 2025 11:11am
Fierce Pharma
Massachusetts shed R&D, manufacturing workers in '24: report
Aug 27, 2025 9:34am
HHS axes Moderna's $590M pandemic bird flu vaccine contract
May 29, 2025 4:30am
Eikon blames US cuts for 15% staff reduction
May 22, 2025 7:55am
NIH terminated $1.8B in grants in 40 days under Trump: study
May 9, 2025 3:04am
